Vaspin promotes 3T3-L1 preadipocyte differentiation

Experimental Biology and Medicine

Volumn 240, Issue 11, 2015, Pages 1520-1527

  Liu, Ping ^a,b   Li, Guoliang ^a   Wu, Jine ^a   Zhou, Xin ^a   Wang, Liping ^b   Han, Wenqi ^a   Lv, Ying ^a   Sun, Chaofeng ^a  

^a The First Affiliated Hospital of Xi an Jiaotong University College of Medicine   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

adipogenesis; Obesity; preadipocyte; vaspin

Indexed keywords

ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; FATTY ACID BINDING PROTEIN 4; GLUCOSE TRANSPORTER 4; INSULIN; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; VASPIN; ADIPOCYTOKINE; AZO COMPOUND; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; CEBPA PROTEIN, MOUSE; CEBPB PROTEIN, MOUSE; FABP4 PROTEIN, MOUSE; FATTY ACID BINDING PROTEIN; INTERLEUKIN-6, MOUSE; LIPID; OIL RED O; SERINE PROTEINASE INHIBITOR; SLC2A4 PROTEIN, MOUSE; VASPIN PROTEIN, MOUSE;

3T3 CELL LINE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; INSULIN RESISTANCE; LIPID STORAGE; MOUSE; MTT ASSAY; NONHUMAN; OBESITY; PROADIPOCYTE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STAINING; WESTERN BLOTTING; ADIPOCYTE; ANIMAL; CHEMISTRY; CYTOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOKINES; ANIMALS; AZO COMPOUNDS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; FATTY ACID-BINDING PROTEINS; GLUCOSE TRANSPORTER TYPE 4; INTERLEUKIN-6; LIPIDS; MICE; PPAR GAMMA; SERPINS; SIGNAL TRANSDUCTION;

EID: 84945973249     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214565081     Document Type: Article

References (34)

1. P.HossainB.KawarM.E.Nahas. Obesity and diabetes in the developing world – a growing challenge. N Engl J Med2007; 356: 213–5.
2. L.F.Van GaalI.L.MertensC.E.De Block. Mechanisms linking obesity with cardiovascular disease. Nature2006; 444: 875–80.
3. K.E.WellenG.S.Hotamisligil. Inflammation, stress, and diabetes. J Clin Invest2005; 115: 1111–9.
4. A.H.BergP.E.Scherer. Adipose tissue, inflammation, and cardiovascular disease. Circ Res2005; 96: 939–49.
5. S.E.WozniakL.L.GeeM.S.WachtelE.E.Frezza. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci2009; 54: 1847–56.
6. E.E.KershawJ.S.Flier. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab2004; 89: 2548–56.
7. W.P.CawthornJ.K.Sethi. TNF-alpha and adipocyte biology. FEBS Lett2008; 582: 117–31.
8. N.SternE.OsherY.Greenman. Hypoadiponectinemia as a marker of adipocyte dysfunction – part II: the functional significance of low adiponectin secretion. J Cardiometab Syndr2007; 2: 288–94.
9. I.DahlmanP.Arner. Obesity and polymorphisms in genes regulating human adipose tissue. Int J Obes (Lond)2007; 31: 1629–41.
10. B.M.SpiegelmanJ.S.Flier. Adipogenesis and obesity: rounding out the big picture. Cell1996; 87: 377–89.
11. F.I.AchikeN.-H.P.ToH.WangC.-Y.Kwan. Obesity, metabolic syndrome, adipocytes and vascular function: a holistic viewpoint. Clin Exp Pharmacol Physiol2011; 38: 1–10.
12. S.R.Farmer. Transcriptional control of adipocyte formation. Cell Metab2006; 4: 263–73.
13. K.HidaJ.WadaJ.EguchiH.ZhangM.BabaA.SeidaI.HashimotoT.OkadaA.YasuharaA.NakatsukaK.ShikataS.HouraiJ.FutamiE.WatanabeY.MatsukiR.HiramatsuS.AkagiH.MakinoY.S.Kanwar. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA2005; 102: 10610–5.
14. N.KlötingP.KovacsM.KernJ.T.HeikerM.FasshauerM.R.SchönM.StumvollA.G.Beck-SickingerM.Blüher. Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia2011; 54: 1819–23.
15. J.T.Heiker. Vaspin (serpinA12) in obesity, insulin resistance, and inflammation. J Pept Sci2014; 20: 299–306.
16. A.HandisuryaM.RiedlG.VilaC.MaierM.ClodiT.PrikoszovichB.LudvikG.PragerA.LugerA.Kautzky-Willer. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg2010; 20: 198–203.
17. N.KlötingJ.BerndtS.KralischP.KovacsM.FasshauerM.R.SchönM.StumvollM.Blüher. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun2006; 339: 430–6.
18. O.G.ShakerN.A.H.Sadik. Vaspin gene in rat adipose tissue: relation to obesity-induced insulin resistance. Mol Cell Biochem2013; 373: 229–39.
19. B.S.YounN.KlötingJ.KratzschN.LeeJ.W.ParkE.S.SongK.RuschkeA.OberbachM.FasshauerM.StumvollM.Blüher. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes2008; 57: 372–7.
20. T.YamauchiJ.KamonH.WakiK.MurakamiK.MotojimaK.KomedaT.IdeN.KubotaY.TerauchiK.TobeH.MikiA.TsuchidaY.AkanumaR.NagaiS.KimuraT.Kadowaki. Mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPAR gamma) deficiency and PPAR gamma agonist improve insulin resistance. J Biol Chem2001; 276: 41245–54.
21. M.HassanN.LatifM.Yacoub. Adipose tissue: friend or foe?Nat Rev Cardiol2012; 9: 689–702.
22. Q.Q.TangT.C.OttoM.D.Lane. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc Natl Acad Sci USA2003; 100: 44–9.
23. F.M.GregoireC.M.SmasH.S.Sul. Understanding adipocyte differentiation. Physiol Rev1998; 78: 783–809.
24. J.F.XuK.Liao. Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation. J Biol Chem2004; 279: 35914–22.
25. C.J.GreenO.GöranssonG.S.KularN.R.LeslieA.GrayD.R.AlessiK.SakamotoH.S.Hundal. Use of AKT inhibitor and a drug-resistant mutant validates a critical role for protein kinase B/AKT in the insulin-dependent regulation of glucose and system A amino acid uptake. J Biol Chem2008; 283: 27653–67.
26. J.-Z.GaoR.-D.ZhengC.-B.WangY.-Q.YingX.-P.Luo. Effects of PI3K inhibitor LY294002 on the differentiation of mouse preadipocytes and the expression of C/EBPalpha and PPARgamma. Zhongguo dang dai er ke za zhi = Chin J Contemporary Pediatr2011; 13: 823–6 [Article in Chinese].
27. C.A.GrimesR.S.Jope. The multifaceted roles of glycogen synthase kinase 3 beta in cellular signaling. Prog Neurobiol2001; 65: 391–426.
28. S.E.RossR.L.EricksonN.HematiO.A.MacDougald. Glycogen synthase kinase 3 is an insulin-regulated C/EBP alpha kinase. Mol Cell Biol1999; 19: 8433–41.
29. H.LiW.PengJ.ZhuangY.LuW.JianY.WeiW.LiY.Xu. Vaspin attenuates high glucose-induced vascular smooth muscle cells proliferation and chemokinesis by inhibiting the MAPK, PI3K/AKT, and NF-kappa B signaling pathways. Atherosclerosis2013; 228: 61–8.
30. I.J.NeelandA.T.TurerC.R.AyersT.M.Powell-WileyG.L.VegaR.Farzaneh-FarS.M.GrundyA.KheraD.K.McGuireJ.A.de Lemos. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA2012; 308: 1150–9.
31. J.G.KangC.Y.ParkS.H.IhmH.J.YooH.ParkE.J.RheeJ.C.WonW.Y.LeeK.W.OhS.W.ParkS.W.Kim. Mechanisms of adipose tissue redistribution with rosiglitazone treatment in various adipose depots. Metabolism2010; 59: 46–53.
32. O.DubuissonE.J.DhurandharR.KrishnapuramH.Kirk-BallardA.K.GuptaV.HegdeE.FloydJ.M.GimbleN.V.Dhurandhar. PPAR gamma-independent increase in glucose uptake and adiponectin abundance in fat cells. Endocrinology2011; 152: 3648–60.
33. Y.-C.ChangH.-J.Cho. Ascofuranone stimulates expression of adiponectin and peroxisome proliferator activated receptor through the modulation of mitogen activated protein kinase family members in 3T3-L1, murine pre-adipocyte cell line. Biochem Biophys Res Commun2012; 422: 423–8.
34. T.SkurkC.Alberti-HuberC.HerderH.Hauner. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab2007; 92: 1023–33.